MedTrace Logo

BurstDR Stimulation for Painful Diabetic Neuropathy

NCT05985291 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2025-11-06

No results posted yet for this study

Summary

This study aims to demonstrate treatment outcomes of Painful Diabetic Neuropathy (PDN) patients treated with BurstDRTM Spinal Cord Dorsal Column Stimulator (SCS) along with conservative medical management per standard of care.

Conditions

  • Painful Diabetic Neuropathy

Interventions

COMBINATION_PRODUCT

SCS in combination with CMM

Subjects receiving BurstDR spinal cord dorsal column stimulation in combination with conservative medical management for the treatment of painful diabetic neuropathy as part of regular medical care.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Mansoor Aman, MD · Aurora Healthcare

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2025-10-06
Completion
2025-10-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05985291 on ClinicalTrials.gov